Cubist Pharma (CBST): Q4 EPS of $0.48 in-line. Revenue of $245.9M (+16% Y/Y) misses by $0.52M....

|By:, SA News Editor
Cubist Pharma (CBST): Q4 EPS of $0.48 in-line. Revenue of $245.9M (+16% Y/Y) misses by $0.52M. Shares +0.8% AH. (PR)